{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:46:57Z","timestamp":1762321617426},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pnpbp.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T17:06:22Z","timestamp":1466960782000},"page":"103-107","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Dysregulation of hypothalamic modulation in olanzapine treated male rats"],"prefix":"10.1016","volume":"71","author":[{"given":"Deniz","family":"Sezlev-Bilecen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2016.06.012_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.2278","article-title":"Olanzapine and food craving: a case control study","volume":"28","author":"Abbas","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psyneuen.2012.06.012","article-title":"The investigation of leptin and hypothalamic neuropeptides role in first attack psychotic male patients: olanzapine monotherapy","volume":"38","author":"Ak","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb2025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and Tissue Distribution of Olanzapine in Rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.psyneuen.2007.12.002","article-title":"Beacon-like\/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia","volume":"33","author":"Bernstein","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.physbeh.2004.04.021","article-title":"Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption?","volume":"82","author":"Blundell","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hup.2288","article-title":"Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain","volume":"28","author":"Brandl","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00406-011-0282-7","article-title":"Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis","volume":"262","author":"Busse","year":"2012","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.pnpbp.2016.06.012_bb2000","first-page":"87","volume":"14","author":"Bymaster","year":"1996","journal-title":"Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine, Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0055","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/endo.140.6.6829","article-title":"Altered expression of agouti-related protein and its colocalization with neuropeptide Y in the arcuate nucleus of the hypothalamus during lactation","volume":"140","author":"Chen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2003.12.004","article-title":"Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice","volume":"999","author":"Chen","year":"2004","journal-title":"Brain Res."},{"issue":"110","key":"10.1016\/j.pnpbp.2016.06.012_bb0065","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/endo.138.10.5570","article-title":"Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus","volume":"138","author":"Cheung","year":"1997","journal-title":"Endocrinology"},{"issue":"13","key":"10.1016\/j.pnpbp.2016.06.012_bb0070","first-page":"532","article-title":"A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples","volume":"15","author":"Chomczynski","year":"1993","journal-title":"Biotechniques"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0075","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/JCP.0b013e31827772db","article-title":"Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain","volume":"33","author":"Czerwensky","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00213-008-1415-1","article-title":"Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine","volume":"203","author":"Davoodi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"23","key":"10.1016\/j.pnpbp.2016.06.012_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","article-title":"Metabolic and endocrine adverse effects of second generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice","volume":"26","author":"De Hert","year":"2011","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0090","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","article-title":"Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique","volume":"31","author":"Fatemi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0095","doi-asserted-by":"crossref","first-page":"e20571","DOI":"10.1371\/journal.pone.0020571","article-title":"Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation","volume":"6","author":"Fern\u00f8","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb2010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jn\/134.2.295","article-title":"Energy Homeostasis, Obesity and Eating Disorders, Recent Advances in Endocrinology","volume":"134","author":"Gale","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb2020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JCP.0b013e3182900c9e","article-title":"Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain","volume":"33","author":"Godlewska","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.pmbts.2015.12.002","article-title":"Rare syndromes and common variants of the brain-derived neurotrophic factor gene in human obesity","volume":"140","author":"Han","year":"2016","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"5581","key":"10.1016\/j.pnpbp.2016.06.012_bb0105","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine","volume":"297","author":"Heisler","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb2005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","article-title":"Central Serotonin and Melanocortin Pathways Regulating Energy Homeostasis","volume":"994","author":"Heisler","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1749-6632.2002.tb04293.x","article-title":"Leptin signaling, adiposity and energy balance","volume":"967","author":"Jequier","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1-3","key":"10.1016\/j.pnpbp.2016.06.012_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr. Res."},{"issue":"501\u2013503","key":"10.1016\/j.pnpbp.2016.06.012_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejphar.2004.10.015","article-title":"Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.","volume":"505","author":"Kirk","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"56","key":"10.1016\/j.pnpbp.2016.06.012_bb0130","article-title":"Neuro-hormonal control of food intake: basic mechanisms and clinical implications.","volume":"56","author":"Konturek","year":"2005","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"issue":"286","key":"10.1016\/j.pnpbp.2016.06.012_bb0150","first-page":"1051","article-title":"Leptin inhibits hypothalamic Npy and Agrp gene expression via a mechanism that requires phosphatidylinositol 3-OH-kinase signaling.","volume":"289","author":"Morrison","year":"2005","journal-title":"AJP - Endo"},{"issue":"9","key":"10.1016\/j.pnpbp.2016.06.012_bb0160","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2016.06.012_bb2015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"6778","key":"10.1016\/j.pnpbp.2016.06.012_bb0170","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pnpbp.2016.06.012_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry."},{"issue":"38","key":"10.1016\/j.pnpbp.2016.06.012_bb0180","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.pnpbp.2011.07.017","article-title":"Effects of antipsychotics with different weightgain liabilities on human in vitro models of adipose tissue differentiation and metabolism.","volume":"35","author":"Serti\u00e9","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JCP.0b013e31827d145a","article-title":"Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients","volume":"33","author":"Tiwari","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.012_bb0195","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.npp.1300626","article-title":"Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride","volume":"30","author":"Wagner","year":"2005","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616301014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616301014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T06:49:10Z","timestamp":1568098150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616301014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":36,"alternative-id":["S0278584616301014"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.012","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of hypothalamic modulation in olanzapine treated male rats","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}